Over the past year, many Cencora, Inc. ( NYSE:COR ) insiders sold a significant stake in the company which may have... CONSHOHOCKEN, Pa., February 07, 2025--Cencora, Inc. (NYSE: COR) today ...
we can get a feel for how investor attitudes to a company have morphed over time. During five years of share price growth, Cencora achieved compound earnings per share (EPS) growth of 18% per year.
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
免费获得Cencora Inc(COR)期权数据。查看选定到期日的Cencora Inc个股期权的认购、认沽执行价格、最新价、涨跌幅、成交量及更多股票期权相关信息。点击“分析”可查看Cencora Inc股票期权的未平仓合约分析表格。
Last week, representatives from Cencora, formerly known as Amerisource Bergen, visited Keystone Health to gain insights into community health centers and their 340B programs. Joy Rowan and Joel ...
In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro talks about how collaborations, like the one with Celltrion, have been instrumental in the company's success. Ian ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果